Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

910
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
910

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HDAC9 promotes atherosclerosis by suppressing CYP7A1 and impairing hepatic cholesterol excretion.

Clinical science (London, England : 1979)·2026
Same author

A psychological network analysis of parental and peer support on children's football participation: the bridging role of self-efficacy.

Frontiers in psychology·2026
Same author

An artificial neuromorphic interface for auditory restoration.

Nature materials·2026
Same author

RECQ4 arginine methylation suppresses single-stranded DNA gap accumulation at replication forks.

Nucleic acids research·2026
Same author

Adjusted Relationships Between Mean Arterial Pressure, Cardiac Index, and Tissue Oxygenation During Off-Pump Coronary Bypass.

Anesthesiology·2026
Same author

Macrophage PSRC1 attenuates atherosclerosis via extracellular vesicle-mediated MBD2 delivery to induce PCSK9 promoter methylation in hepatocytes.

Cell & bioscience·2026

Related Experiment Video

Updated: Jul 2, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K

TIPE2: A Candidate for Targeting Antitumor Immunotherapy.

Luxia Xu1, Feiyan Pan1, Zhigang Guo1

  • 1Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China.

Journal of Immunology (Baltimore, Md. : 1950)
|February 20, 2024
PubMed
Summary

TNF-α-induced protein 8-like 2 (TIPE2) is a key regulator of immune responses and inflammation. Further research is needed to fully understand TIPE2

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

519

Related Experiment Videos

Last Updated: Jul 2, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

519

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • TNF-α-induced protein 8-like 2 (TIPE2) is a novel negative regulator of innate and adaptive immunity.
  • TIPE2 maintains immune homeostasis and is involved in inflammation and tumor development.
  • Its expression spans various immune and non-immune tissues.

Approach:

  • This review synthesizes current knowledge on TIPE proteins, focusing on TIPE2.
  • It examines TIPE2's structure, expression, and function in immune regulation.
  • The review also explores TIPE2's role in various diseases.

Key Points:

  • TIPE2 is crucial for immune homeostasis and inflammation control.
  • It plays a significant role in tumor development.
  • Understanding TIPE2's mechanisms is vital for disease research.

Conclusions:

  • TIPE2 is a critical regulator of immune responses with implications for health and disease.
  • Current understanding of TIPE2's complex roles is limited.
  • Further investigation is necessary to elucidate TIPE2's functions in diverse disease contexts.